$.001 per share; 20,000,000
authorized; 14,332,210 and
13,709,098 shares issued and
outstanding, respectively 14,000 14,000
Additional paid-in capital 29,870,000 26,953,000
Accumulated other comprehensive
income (209,000) 321,000
Retained earnings 14,304,000 9,818,000
43,979,000 37,106,000
Less: cost of 286,478 and 270,534
shares of common stock in treasury,
respectively (2,013,000) (1,971,000)
Less: unearned compensation (4,947,000) (2,715,000)
Total Stockholders' Equity 37,019,000 32,420,000
TOTAL LIABILITIES AND
STOCKHOLDERS' EQUITY $49,376,000 $43,724,000
MEDIFAST, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
Three Months Ended Nine Months Ended
September 30, September 30,
2008 2007 2008 2007
Revenue $27,281,000 $21,846,000 $79,987,000 $63,975,000
Cost of sales 6,522,000 5,523,000 19,299,000 15,944,000
Gross Profit 20,759,000 16,323,000 60,688,000 48,031,000
Selling, general, and
administration 18,363,000 14,766,000 53,820,000 43,116,000
Income from operations 2,396,000 1,557,000 6,868,000 4,915,000
Other income/(expense)
Interest expense,
net (50,000) (159,000) (159,000) (284,000)
'/>"/>
| SOURCE Medifast, Inc. Copyright©2008 PR Newswire. All rights reserved |